Welcome back, everyone. We hope your weekend was enjoyable. Here in the US, of course, this will be a short week for many people. Nonetheless, there is always something to do. So as you gear up for those meetings, deadlines and projects, here are a few items to help you along your way...
Johnson & Johnson To Pay $465M For Omrix (Globes)
Avastin Meets Primary Goal In Breast-Cancer Study (PharmaTimes)
India's Communists Cry Foul Over WHO Counterfeit Plan (The Hindu)
SurModics To Restructure And Cut Jobs (CNN/Associated Press)
Vical Cuts Jobs And Closes Facility (Reuters)